Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.
2.

Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effects of FcRn Inhibitors in Mice, Rats, and Monkeys.

Li T, Balthasar JP.

J Pharm Sci. 2019 Jan;108(1):701-713. doi: 10.1016/j.xphs.2018.10.065. Epub 2018 Nov 10.

PMID:
30423340
3.

FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues.

Li T, Balthasar JP.

Biomolecules. 2018 Oct 15;8(4). pii: E115. doi: 10.3390/biom8040115.

4.

"Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.

Engler FA, Polli JR, Li T, An B, Otteneder M, Qu J, Balthasar JP.

J Pharmacol Exp Ther. 2018 Jul;366(1):205-219. doi: 10.1124/jpet.117.246900. Epub 2018 May 7.

PMID:
29735609
5.

Investigation of the Influence of Protein-Losing Enteropathy on Monoclonal Antibody Pharmacokinetics in Mice.

Yang Y, Li TR, Balthasar JP.

AAPS J. 2017 Nov;19(6):1791-1803. doi: 10.1208/s12248-017-0135-z. Epub 2017 Aug 28.

PMID:
28849396

Supplemental Content

Loading ...
Support Center